Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Politics, Policy & Law

Plotting a scientific path to counter COVID-19

How COVID-19 response is stimulating global scientific collaboration

February 27, 2020 12:55 AM UTC
Updated on Mar 25, 2020 at 12:16 AM UTC

In a global online forum Tuesday night, scientific leaders from companies developing vaccines, therapies and diagnostics to address the COVID-19 outbreak discussed opportunities for collaboration, highlighted challenges, and called for sustained global initiatives to create medical countermeasures to emerging infections.

Participants in the forum, which was sponsored by WuXi Apptec Co. Ltd. (Shanghai:603259; HKEX:2359), provided updates on vaccine development progress, stressed the need to develop multiple vaccines, and called for the establishment of master protocols to efficiently test the candidates. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article